Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Chief Financial Officer | December 07, 2020 | December 07, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KORU Medical Systems, Inc.
Report date December 07, 2020 · Filed December 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 572,906 |
Reported balance
After 2020-12-07 transaction · row 1
1 source rowRow 1 · 2020-12-07 · Purchase · Acquired 500 · Balance 572,906 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2020 Filed Dec 7, 2020 21:42 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 500 | $5.60 | $2,800.00 |
DisclosureSEC source: 0001161697-20-000521 · form_4.xml · nonDerivative · entry 1 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,906 Read SEC document |
| December 03, 2020 Filed Dec 3, 2020 21:07 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 250 | $5.30 | $1,325.00 |
DisclosureSEC source: 0001161697-20-000516 · form_4.xml · nonDerivative · entry 1 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,406 Read SEC document |
| May 09, 2020 Filed May 11, 2020 21:31 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001161697-20-000201 · form_4.xml · derivative · entry 5 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2020 Filed May 11, 2020 21:31 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 435,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001161697-20-000201 · form_4.xml · derivative · entry 4 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 435,000 shares Expires 2020-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2020 Filed May 11, 2020 21:31 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionCommon Stock | 100,000 | $1.57 | $157,000.00 |
DisclosureSEC source: 0001161697-20-000201 · form_4.xml · nonDerivative · entry 3 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2020 Filed May 11, 2020 21:31 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionCommon Stock | 435,000 | $0.38 | $165,300.00 |
DisclosureSEC source: 0001161697-20-000201 · form_4.xml · nonDerivative · entry 2 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2020 Filed May 11, 2020 21:31 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 27,844 | $11.58 | $322,294.30 |
DisclosureSEC source: 0001161697-20-000201 · form_4.xml · nonDerivative · entry 1 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,156 F1 · kind: Represents the payment of the exercise price of stock options through the delivery of previously owned shares to the issuer. F2 · price: The price is equal to the Fair Market Value of the Common Stock, as defined in the stock option award agreements, and is used to determine the value of the shares delivered to the issuer in payment of the exercise price. Read SEC document |
| May 08, 2019 Filed May 9, 2019 20:15 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | Exercise / conversionOptions to Purchase Common Stock · Derivative | 65,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001161697-19-000193 · form_4.xml · derivative · entry 2 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,000 Underlying: Common Stock · 65,000 shares Expires 2020-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2019 Filed May 9, 2019 20:15 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | Exercise / conversionCommon Stock | 65,000 | $0.38 | $24,700.00 |
DisclosureSEC source: 0001161697-19-000193 · form_4.xml · nonDerivative · entry 1 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2019 Filed Feb 4, 2019 21:41 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantOptions to Purchase Common Stock · Derivative | 500,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001161697-19-000053 · form_4.xml · derivative · entry 1 Fisher Karen · CIK 0001406771 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 500,000 shares Expires 2029-01-29 F1 · derivative.exercise_date: Incentive stock options granted pursuant to the Repro Med Systems, Inc. 2015 Stock Option Plan, as amended. Options vest in increments of 100,000 on the first anniversary of the date of grant and each anniversary thereafter until fully vested. Read SEC document |
| September 06, 2016 Filed Sep 16, 2016 20:08 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantOptions to Purchase Common Stock · Derivative | 500,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001161697-16-001081 · form_4.xml · derivative · entry 1 Fisher Karen · CIK 0001406771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2020-11-04 F1 · date: The Company's Board of Directors awarded these options on November 4, 2015, subject to shareholder approval of the Company's 2015 Stock Option Plan, as amended, which approval was obtained on September 6, 2016. The options vest on November 4, 2016, subject to acceleration upon a change of control of the Company, provided Ms. Fisher is employed with the Company on such date. F1 · derivative.exercise_date: The Company's Board of Directors awarded these options on November 4, 2015, subject to shareholder approval of the Company's 2015 Stock Option Plan, as amended, which approval was obtained on September 6, 2016. The options vest on November 4, 2016, subject to acceleration upon a change of control of the Company, provided Ms. Fisher is employed with the Company on such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.